Doximity’s Strategic Financial And Operational Performance In Fiscal Year 2025

$DOCS

Doximity, Inc. (NYSE:DOCS), a leading digital platform for US medical professionals, has demonstrated significant financial and operational growth throughout fiscal year 2025, marked by robust revenue increases and strategic expansions in its product offerings. In the fiscal quarter ending March 31, 2025, Doximity reported total revenues of $138.3 million, a 17% increase year-over-year.

This growth was driven by a rise in subscription revenues, which also saw a 17% increase from the previous year, amounting to $131.9 million. The company’s net income for the quarter stood at $62.5 million, translating to a net income margin of 45.2%, a significant improvement from 34.4% in the same quarter the previous year.

Doximity’s operational success in fiscal year 2025 was largely fueled by the performance of its newly introduced product modules outside the core news feed, which recorded over 100% year-over-year growth. These products, including point-of-care and formulary modules, now account for 20% of pharmaceutical sales, highlighting their rapid adoption among clients.

For the entire fiscal year 2025, Doximity achieved total revenues of $570.4 million, up 20% from the previous fiscal year. The substantial revenue growth was complemented by a 48% increase in operating cash flow, reaching $273.3 million and a 50% rise in free cash flow, which amounted to $266.7 million.

Doximity provided guidance for the first quarter of fiscal year 2026, projecting revenues between $139 million and $140 million, with adjusted EBITDA expected to range from $71 million to $72 million. For the full fiscal year 2026, the company anticipates revenues to be between $619 million and $631 million, with adjusted EBITDA between $333 million and $345 million. The company moves forward, it will likely maintain its focus on innovation and customer satisfaction, ensuring its position as a key player in the digital healthcare space.

**DISCLAIMER: THIS CONTENT IS FOR INFORMATIONAL PURPOSES ONLY AND SHOULD NOT BE INTERPRETED AS INVESTMENT ADVICE. INVESTING INVOLVES RISK, INCLUDING THE POTENTIAL LOSS OF PRINCIPAL. READERS ARE ENCOURAGED TO CONDUCT THEIR OWN RESEARCH AND CONSULT WITH A QUALIFIED FINANCIAL ADVISOR BEFORE MAKING ANY INVESTMENT DECISIONS.**